Echarri, AnaVera, IsabelArajol, ClaudiaRiestra, SabinoRobledo, PilarCalvo, MartaGallego, FranciscoCeballos, DanielCastro, BeatrizAguas, MiriamGarcía López, SantiagoMarín-Jiménez, IgnacioChaparro, MaríaMesonero, PacoGuerra, IvánGuardiola, JordiNos, PilarMuñiz, Javier2020-01-302020-01-302020-01-07Echarri A, Vera I, Ollero V, et al. The Harvey–Bradshaw Index adapted to a mobile application compared with In-clinic assessment: the MediCrohn Study. Telemed J E Health. 2020; 26(1):78-861530-5627http://hdl.handle.net/2183/24797[Abstract] Objectives: Mobile apps are useful tools in e-health and self-management strategies in disease monitoring. We evaluated the Harvey–Bradshaw index (HBI) mobile app self-administered by the patient to see if its results agreed with HBI in-clinic assessed by a physician. Methods: Patients were enrolled in a 4-month prospective study with clinical assessments at months 1 and 4. Patients completed mobile app HBI and within 48 h, HBI was performed by a physician (gold standard). HBI scores characterized Crohn's disease (CD) as remission <5 or active ≥5. We determined agreement per item and total HBI score and intraclass correlation coefficients (ICCs). Bland–Altman plot was performed. HBI changes in disease activity from month 1 to month 4 were determined. Results: A total of 219 patients were enrolled. All scheduled assessments (385 pairs of the HBI questionnaire) showed a high percentage of agreement for remission/activity (92.4%, κ = 0.796), positive predictive value (PPV) for remission of 98.2%, and negative predictive value of 76.7%. High agreement was also found at month 1 (93.15%, κ = 0.82) and month 4 (91.5%, κ = 0.75). Bland–Altman plot was more uniform when the HBI mean values were <5 (remission). ICC values were 0.82, 0.897, and 0.879 in all scheduled assessments, 1 and 4 months, respectively. Conclusions: We found a high percentage of agreement between patients' self-administered mobile app HBI and in-clinic physician assessment to detect CD activity with a remarkably high PPV for remission. The mobile app HBI might allow a strict control of inflammation by remote monitoring and flexible follow-up of CD patients. Reduction of sanitary costs could be possible.engCreative Commons Attribution 4.0 International License (CC-BY 4.0)http://creativecommons.org/licenses/by/4.0/Behavioral healthE-healthHome health monitoringTelehealthTelemedicinejournal articleopen access